tiprankstipranks
Lipella Pharmaceuticals, Inc. (LIPO)
NASDAQ:LIPO
US Market

Lipella Pharmaceuticals, Inc. (LIPO) Income Statement

Compare
110 Followers

Lipella Pharmaceuticals, Inc. Income Statement

Last quarter (Q3 2024), Lipella Pharmaceuticals, Inc.'s total revenue was $80.38K, a decrease of -99.92% from the same quarter last year. In Q3, Lipella Pharmaceuticals, Inc.'s net income was $-1.44B. See Lipella Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 449.62K$ 184.16K$ 259.35K$ 961.68K$ 694.75K
Gross Profit
$ -2.59M$ -2.36M$ -1.20M$ -14.28K$ 11.86K
Operating Expenses
$ 2.16M$ 2.77M$ 2.18M$ 1.02M$ 748.54K
Depreciation and Amortization
$ 1.69K$ 2.59M$ 1.92M$ 56.86K$ 53.79K
EBITDA
$ -4.61M$ -2.59M$ 0.00$ -53.69K$ 334.00
Operating Income
$ -4.75M$ -2.59M$ -1.92M$ -56.86K$ -53.79K
Other Income/Expenses
$ 126.99K$ -7.98K$ 50.35K$ -4.79K$ -8.06K
Pretax Income
$ -4.62M$ -2.60M$ -1.87M$ -61.66K$ -61.85K
Net Income
$ -4.62M$ -2.60M$ -1.87M$ -66.45K$ -61.85K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -6.16$ -0.45$ -0.33$ -0.01$ -0.01
Diluted EPS
$ -0.77$ -0.45$ -0.33$ -0.01$ -0.01
Weighted Average Shares Outstanding
750.38K 5.74M 5.74M 5.69M 5.69M
Weighted Average Shares Outstanding (Diluted)
6.00M 5.74M 5.74M 5.69M 5.69M
Currency in USD

Lipella Pharmaceuticals, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis